Clinical Trial Update: Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LYM-X-SORB to improve fatty acid and choline status in children with cystic fibrosis and pancreatic insufficiency has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Insufficiency

Drugs mentioned

• LYM-X-SORB

Snippet

Sponsor: Avanti Polar Lipids, Inc. | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | Phase 2 | Status: COMPLETED